Evidence map›Paper›PMID 40197050›Full record

ArticleNano letters2025

Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.

Göktuğ Aba, Subinuer Abudukelimu, Margot de Winter, Gabriella Collu, Erik Bos, Sebastiaan M W R Hamers, Lukas J A C Hawinkels, Nadine van Montfoort, Ferenc A Scheeren, Thomas H Sharp

Abstract read
In one paragraph

Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Göktuğ AbaDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.ORCID 0000-0002-3655-3745
Subinuer AbudukelimuDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Margot de WinterDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Gabriella ColluDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Erik BosDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Sebastiaan M W R HamersDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Lukas J A C HawinkelsDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Nadine van MontfoortDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Ferenc A ScheerenDepartment of Dermatology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.
Thomas H SharpDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZG Leiden, The Netherlands.ORCID 0000-0002-1990-2333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clustering of type-II tumor necrosis factor receptors (TNFRs) is required to induce intracellular signaling. Current methods for receptor clustering lack precise control over ligand valency and spatial organization, potentially limiting optimal TNFR activation, biological insight, and therapeutic efficacy. DNA nanostructures provide nanometer-precise control over molecular arrangement, allowing control of both ligand spacing and valency. Here, we produce a DNA nanostructure decorated with controlled numbers of engineered single-chain TNF-related apoptosis-inducing ligand (sc-TRAIL) trimers, which bind death receptor 5 (DR5) with native affinity and geometry and enable investigation of the geometric parameters influencing apoptotic pathway activation. We show that cell killing is affected by receptor valency and separation and enhanced by superclustering sc-TRAIL trimers, which can induce cell killing in human primary pancreatic and colorectal cancer organoids. Together, our data show that control of receptor superclustering enhances our understanding of receptor activation mechanisms and informs the development of more effective cancer therapies.

Indexed as

Colorectal NeoplasmsDNANanostructuresPancreatic NeoplasmsReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandApoptosisCell Line, TumorHumansDNAReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanCell killingDeath receptorDNA nanotechnologyImmunologyNanomedicineTRAIL

Identifiers

PMID40197050
PMCPMC12007100

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.